230 related articles for article (PubMed ID: 31975481)
1. Bone sarcomas in the immunotherapy era.
Heymann MF; Schiavone K; Heymann D
Br J Pharmacol; 2021 May; 178(9):1955-1972. PubMed ID: 31975481
[TBL] [Abstract][Full Text] [Related]
2. Emerging trends in immunotherapy for pediatric sarcomas.
Dyson KA; Stover BD; Grippin A; Mendez-Gomez HR; Lagmay J; Mitchell DA; Sayour EJ
J Hematol Oncol; 2019 Jul; 12(1):78. PubMed ID: 31311607
[TBL] [Abstract][Full Text] [Related]
3. Oxysterols in cancer management: From therapy to biomarkers.
Kloudova-Spalenkova A; Holy P; Soucek P
Br J Pharmacol; 2021 Aug; 178(16):3235-3247. PubMed ID: 32986851
[TBL] [Abstract][Full Text] [Related]
4. Biology of Bone Sarcomas and New Therapeutic Developments.
Brown HK; Schiavone K; Gouin F; Heymann MF; Heymann D
Calcif Tissue Int; 2018 Feb; 102(2):174-195. PubMed ID: 29238848
[TBL] [Abstract][Full Text] [Related]
5. Non-coding RNAs in bone remodelling and bone metastasis: Mechanisms of action and translational relevance.
Puppo M; Taipaleenmäki H; Hesse E; Clézardin P
Br J Pharmacol; 2021 May; 178(9):1936-1954. PubMed ID: 31423566
[TBL] [Abstract][Full Text] [Related]
6. Cellular metabolism and diseases.
Maiuri MC; Maffia P
Br J Pharmacol; 2021 May; 178(10):2031-2033. PubMed ID: 33932230
[TBL] [Abstract][Full Text] [Related]
7. A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
Antman K; Crowley J; Balcerzak SP; Kempf RA; Weiss RB; Clamon GH; Baker LH
Cancer; 1998 Apr; 82(7):1288-95. PubMed ID: 9529020
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of bisphosphonates in pain.
Tzschentke TM
Br J Pharmacol; 2021 May; 178(9):1973-1994. PubMed ID: 31347149
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targets in myeloma bone disease.
Marino S; Petrusca DN; Roodman GD
Br J Pharmacol; 2021 May; 178(9):1907-1922. PubMed ID: 31647573
[TBL] [Abstract][Full Text] [Related]
10. Sarcomas-A barren immunological wasteland or field of opportunity for immunotherapy?
Atherton MJ; Lenz JA; Mason NJ
Vet Comp Oncol; 2020 Dec; 18(4):447-470. PubMed ID: 32246517
[TBL] [Abstract][Full Text] [Related]
11. Endothelial cell and T-cell crosstalk: Targeting metabolism as a therapeutic approach in chronic inflammation.
Certo M; Elkafrawy H; Pucino V; Cucchi D; Cheung KCP; Mauro C
Br J Pharmacol; 2021 May; 178(10):2041-2059. PubMed ID: 31999357
[TBL] [Abstract][Full Text] [Related]
12. Emerging areas of opioid pharmacology.
Kelly E; Henderson G; Bailey CP
Br J Pharmacol; 2018 Jul; 175(14):2715-2716. PubMed ID: 29939423
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates for delivering drugs to bone.
Sun S; Tao J; Sedghizadeh PP; Cherian P; Junka AF; Sodagar E; Xing L; Boeckman RK; Srinivasan V; Yao Z; Boyce BF; Lipe B; Neighbors JD; Russell RGG; McKenna CE; Ebetino FH
Br J Pharmacol; 2021 May; 178(9):2008-2025. PubMed ID: 32876338
[TBL] [Abstract][Full Text] [Related]
14. Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective.
Basudhar D; Bharadwaj G; Somasundaram V; Cheng RYS; Ridnour LA; Fujita M; Lockett SJ; Anderson SK; McVicar DW; Wink DA
Br J Pharmacol; 2019 Jan; 176(2):155-176. PubMed ID: 30152521
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapies for bone sarcomas.
Heymann D; Rédini F
Bonekey Rep; 2013 Jul; 2():378. PubMed ID: 24422100
[TBL] [Abstract][Full Text] [Related]
16. Current and future treatments of pulmonary arterial hypertension.
Sommer N; Ghofrani HA; Pak O; Bonnet S; Provencher S; Sitbon O; Rosenkranz S; Hoeper MM; Kiely DG
Br J Pharmacol; 2021 Jan; 178(1):6-30. PubMed ID: 32034759
[TBL] [Abstract][Full Text] [Related]
17. Overview of treatment approaches to osteoporosis.
Langdahl BL
Br J Pharmacol; 2021 May; 178(9):1891-1906. PubMed ID: 32060897
[TBL] [Abstract][Full Text] [Related]
18. Oxysterols: From physiological tuners to pharmacological opportunities.
Brown AJ; Sharpe LJ; Rogers MJ
Br J Pharmacol; 2021 Aug; 178(16):3089-3103. PubMed ID: 32335907
[TBL] [Abstract][Full Text] [Related]
19. Artificial intelligence for solid tumour diagnosis in digital pathology.
Klein C; Zeng Q; Arbaretaz F; Devêvre E; Calderaro J; Lomenie N; Maiuri MC
Br J Pharmacol; 2021 Nov; 178(21):4291-4315. PubMed ID: 34302297
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic dissemination of bone and soft tissue sarcomas: a lymphographic investigation.
Tallroth K
Acta Radiol Suppl; 1976; 349():1-84. PubMed ID: 206099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
